|
PCF11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.962210E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.309800E-02 |
| Normal-vs-Stage2 |
1.807970E-01 |
| Normal-vs-Stage3 |
2.09069999999034E-05 |
| Normal-vs-Stage4 |
1.022440E-02 |
| Stage1-vs-Stage2 |
9.831200E-01 |
| Stage1-vs-Stage3 |
3.715100E-03 |
| Stage1-vs-Stage4 |
2.018800E-01 |
| Stage2-vs-Stage3 |
1.294390E-01 |
| Stage2-vs-Stage4 |
3.517800E-01 |
| Stage3-vs-Stage4 |
9.061800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.666390E-02 |
| Normal-vs-AfricanAmerican |
5.376100E-02 |
| Normal-vs-Asian |
7.520800E-01 |
| Caucasian-vs-AfricanAmerican |
7.603800E-01 |
| Caucasian-vs-Asian |
7.887600E-01 |
| AfricanAmerican-vs-Asian |
8.353600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.183900E-03 |
| Normal-vs-Female |
1.429600E-01 |
| Male-vs-Female |
1.687970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.425600E-02 |
| Normal-vs-Extreme_Weight |
7.479100E-03 |
| Normal-vs-Obese |
9.288000E-02 |
| Normal-vs-Extreme_Obese |
4.593600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.075800E-01 |
| Normal_Weight-vs-Obese |
8.105400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.557600E-01 |
| Extreme_Weight-vs-Obese |
3.004400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.177400E-01 |
| Obese-vs-Extreme_Obese |
5.388600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.812000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.738190E-01 |
| Normal-vs-Age(61-80Yrs) |
3.456000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.340200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.277600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.243600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.558370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.549700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.139900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.132800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.030950E-01 |
| Normal-VS-Type2 PRCC |
1.69532999999555E-05 |
| Normal-VS-KIRP CIMP |
3.637800E-03 |
| Normal-VS-Unclassified PRCC |
7.310000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.73280000000231E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.346300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.366400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.379000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.632300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.205600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.038000E-04 |
| Normal-vs-N1 |
2.436800E-03 |
| Normal-vs-N2 |
1.799640E-03 |
| N0-vs-N1 |
7.967400E-01 |
| N0-vs-N2 |
7.457900E-02 |
| N1-vs-N2 |
1.294800E-01 |
|
|
